Our comprehensive strategy consulting practice has been organized in the following key services:

Technology Assessment
  • Strategic Evaluation of New and Emerging Technologies
  • Assessment of Commercial Viability of New Products
  • Technical and Market Due Diligence
  • Primary Research with Clinical Thought Leaders
  • Valuation Analysis
  • Patent Portfolio Analysis
Strategic Market Research
  • Primary and Secondary Market Research to Evaluate Market Potential of New Technologies
  • Primary Research on Thought Leader Perspective on Critical Clinical Issues
  • Financial Forecasting on US and Global Market Potential
Strategy Consulting
  • Identifying and evaluating key opportunities and threats to core businesses
  • Developing viable strategic options in entering key market segments
  • Strategic and Tactical Planning
  • Business Planning
  • Financial Forecasting
  • Competitive Intelligence
Corporate Development Consulting
  • Product positioning and profiling
  • Identification and Assessment of Potential Corporate Partners
  • M&A Support and Due Diligence
  • Negotiation of Partnering Deals
  • Valuation Analysis
Venture Development
  • Identification and Assessment of Key Portfolio Investment Targets
  • Executive Management and Oversight of Development Stage Companies
  • Strategic Business Planning to Maximize Value Creation
  • Management of Venture Exit at Optimal Valuation
Regulatory and Reimbursement Strategy Consulting
  • Strategic Planning for US FDA and European Product Registration
  • Development and Validation of FDA Strategy Through Input from FDA Insiders
  • Preparations and Submissions of Filings (e.g., IDE, 510(k), PMA)
  • Coverage, coding, and payment analysis, planning, and implementation